PF-07245303 is a potent, selective, non-peptidic small molecule inhibitor of the protein kinase CK2, currently under investigation for its potential to treat various cancers by disrupting critical cellular… Read more
PF-07245303 is a potent, selective, non-peptidic small molecule inhibitor of the protein kinase CK2, currently under investigation for its potential to treat various cancers by disrupting critical cellular regulatory functions. This category provides essential analytical tools, including the parent drug, a specific impurity, and a stable isotope labelled internal standard, designed to support rigorous pharmaceutical research and development. Laboratories rely on these high-quality reference standards for comprehensive impurity profiling and to ensure the accuracy of method validation protocols. By utilizing the 13C-d3 labelled version, researchers can perform precise mass spectrometry calibration and quantitative analysis, ensuring the specificity and reliability of assays. These materials are fundamental for maintaining stringent quality control standards throughout the investigation of this CK2 inhibitor and its related compounds during the drug development lifecycle.